Dr Peter Farrell
Dr. Peter C. Farrell, Founder and Chairman of ResMed, believes in giving back. For several years he has been a stalwart supporter of universities, primary and secondary education activities, as well as various arts and cultural organizations in the United States, Australia and elsewhere.
Before founding ResMed, Dr. Farrell served as Vice President of Research and Development at various subsidiaries of Baxter International, Inc. and as Managing Director of the Baxter Center for Medical Research.
He served on the Visiting Committee of the Harvard/Massachusetts Institute of Technology Health Sciences & Technology Program from 1998 through 2018, and currently serves on the MIT Dean of Engineering’s Advisory Council.
Dr. Farrell has served on several boards, including chairman at Arcturus Therapeutics Ltd and on two faculty advisory boards at the University of California. Dr. Farrell is a fellow or honorary fellow of several professional bodies. In 2012, he became an elected member of the National Academy of Engineering and joined the board of trustees of Scripps Research.
He was named 2005 U.S. National Entrepreneur of the Year for Health Sciences and 1998 San Diego Entrepreneur of the Year for Health Sciences.
In 2001, the same year Peter Farrell was awarded Australian Entrepreneur of the year, UNSW launched the Peter Farrell Cup as Australia's first ever pitching competition for student-led startups.
Now in it’s 21st year, the Peter Farrell Cup, is fast-tracking the next generation of entrepreneurs by giving them access to the knowledge, tools, expertise and learning environment they need for their ideas to flourish.
The establishment and ongoing success of the PFC has been made possible through the ongoing generous donation from the Farrell Family Foundation.
Dr. Farrell has a B.E. in chemical engineering with Honors from the University of Sydney, an S.M. in chemical engineering from MIT, a Ph.D. in chemical engineering and bioengineering from the University of Washington, Seattle, and a D.Sc. from the University of New South Wales, Sydney, for research contributions in the field of treatment with the artificial kidney.